Combination of the cuproptosis inducer disulfiram and anti ‑PD‑L1 abolishes NSCLC resistance by ATP7B to regulate the HIF‑1 signaling pathway

In conclusion, the combined treatment of A549 cells with anti‑PD‑L1 and DSF enhanced the effect of cuproptosis on the inhibition of NSCLC cell viability.PMID:38186308 | DOI:10.3892/ijmm.2023.5343

Source: International Journal of Molecular Medicine - January 8, 2024 Category: Molecular Biology Authors: Pengfei Li Qi Sun Shuping Bai Haitao Wang Ling Zhao Source Type: research